Want to see GB:THAT full AI Analyst Report?
N4 Pharma (THAT) Income Statement
N4 Pharma Income Statement
Last quarter (Q2 2026), N4 Pharma's total revenue was $3.64K, an increase of 86.48% from the same quarter last year. In Q2, N4 Pharma's net income was $-754.93K. See N4 Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 7.26K | $ 7.28K | $ 1.95K | $ 0.00 | $ 0.00 | |
| $ 7.26K | $ 7.28K | $ 1.95K | $ 0.00 | $ 0.00 | |
| $ 1.11M | $ 1.17M | $ 1.43M | $ 1.19M | $ 1.84M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 89.17K | $ 228.49K | $ 236.56K |
| $ -1.10M | $ -1.22M | $ -1.33M | $ -1.19M | $ -1.84M | |
| $ -1.10M | $ -1.22M | $ -1.43M | $ -1.19M | $ -1.84M | |
| $ 61.13K | $ -61.21K | $ 0.00 | $ 0.00 | $ 677.00 | |
| $ -1.10M | $ -1.22M | $ -1.43M | $ -1.19M | $ -1.84M | |
| $ -1.21M | $ -1.06M | $ -1.27M | $ -1.03M | $ -1.54M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.00 | $ -0.01 | $ -0.01 | $ -0.01 |
| Diluted EPS | $ -0.00 | $ -0.00 | $ -0.01 | $ -0.01 | $ -0.01 |
| Weighted Average Shares Outstanding | 724.40M | 340.39M | 242.89M | 186.42M | 181.08M |
| Weighted Average Shares Outstanding (Diluted) | 724.40M | 340.88M | 242.89M | 186.42M | 181.08M |
Currency in GBP
